These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18066078)

  • 1. Pot1 and cell cycle progression cooperate in telomere length regulation.
    Churikov D; Price CM
    Nat Struct Mol Biol; 2008 Jan; 15(1):79-84. PubMed ID: 18066078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vertebrate POT1 restricts G-overhang length and prevents activation of a telomeric DNA damage checkpoint but is dispensable for overhang protection.
    Churikov D; Wei C; Price CM
    Mol Cell Biol; 2006 Sep; 26(18):6971-82. PubMed ID: 16943437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.
    Denchi EL; de Lange T
    Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis.
    Guo X; Deng Y; Lin Y; Cosme-Blanco W; Chan S; He H; Yuan G; Brown EJ; Chang S
    EMBO J; 2007 Nov; 26(22):4709-19. PubMed ID: 17948054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM/ATR checkpoint activation downregulates CDC25C to prevent mitotic entry with uncapped telomeres.
    Thanasoula M; Escandell JM; Suwaki N; Tarsounas M
    EMBO J; 2012 Aug; 31(16):3398-410. PubMed ID: 22842784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RPA and POT1: friends or foes at telomeres?
    Flynn RL; Chang S; Zou L
    Cell Cycle; 2012 Feb; 11(4):652-7. PubMed ID: 22373525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pot1 inactivation leads to rampant telomere resection and loss in one cell cycle.
    Pitt CW; Cooper JP
    Nucleic Acids Res; 2010 Nov; 38(20):6968-75. PubMed ID: 20601686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apollo contributes to G overhang maintenance and protects leading-end telomeres.
    Wu P; van Overbeek M; Rooney S; de Lange T
    Mol Cell; 2010 Aug; 39(4):606-17. PubMed ID: 20619712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
    Helt CE; Cliby WA; Keng PC; Bambara RA; O'Reilly MA
    J Biol Chem; 2005 Jan; 280(2):1186-92. PubMed ID: 15533933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the S phase DNA damage checkpoint by mitomycin C.
    Mladenov E; Tsaneva I; Anachkova B
    J Cell Physiol; 2007 May; 211(2):468-76. PubMed ID: 17167777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
    Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ
    Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzo[a]pyrene induces complex H2AX phosphorylation patterns by multiple kinases including ATM, ATR, and DNA-PK.
    Yan C; Lu J; Zhang G; Gan T; Zeng Q; Shao Z; Duerksen-Hughes PJ; Yang J
    Toxicol In Vitro; 2011 Feb; 25(1):91-9. PubMed ID: 20888899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.
    Lee HJ; Hwang HI; Jang YJ
    Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chk1- and claspin-dependent but ATR/ATM- and Rad17-independent DNA replication checkpoint response in HeLa cells.
    Rodríguez-Bravo V; Guaita-Esteruelas S; Florensa R; Bachs O; Agell N
    Cancer Res; 2006 Sep; 66(17):8672-9. PubMed ID: 16951182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect.
    Salvati E; Leonetti C; Rizzo A; Scarsella M; Mottolese M; Galati R; Sperduti I; Stevens MF; D'Incalci M; Blasco M; Chiorino G; Bauwens S; Horard B; Gilson E; Stoppacciaro A; Zupi G; Biroccio A
    J Clin Invest; 2007 Nov; 117(11):3236-47. PubMed ID: 17932567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis.
    Kurose A; Tanaka T; Huang X; Halicka HD; Traganos F; Dai W; Darzynkiewicz Z
    Cytometry A; 2005 Nov; 68(1):1-9. PubMed ID: 16184611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms.
    Siu WY; Lau A; Arooz T; Chow JP; Ho HT; Poon RY
    Mol Cancer Ther; 2004 May; 3(5):621-32. PubMed ID: 15141020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of CHK1 kinase by Gö6976 converts 8-chloro-adenosine-induced G2/M arrest into S arrest in human myelocytic leukemia K562 cells.
    Jia XZ; Yang SY; Zhou J; Li SY; Ni JH; An GS; Jia HT
    Biochem Pharmacol; 2009 Mar; 77(5):770-80. PubMed ID: 19059218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive.
    Guo N; Faller DV; Vaziri C
    Cell Growth Differ; 2002 Feb; 13(2):77-86. PubMed ID: 11864911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.